M. Polée

Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial

Renu R. Bahadoer, Esmée A. Dijkstra, Boudewijn van Etten et al. · The Lancet Oncology · 2020 · 1.6K citations · Full text

Medicine, Oncology, Surgery +17

Prognostic factors for survival in patients with advanced oesophageal cancer treated with cisplatin-based combination chemotherapy

M. Polée, Wim C.J. Hop, T.C. Kok et al. · British Journal of Cancer · 2003 · 97 citations · Full text

Medicine, Oncology, Pharmacology +13

Randomized phase III trial of S-1 versus capecitabine in the first-line treatment of metastatic colorectal cancer: SALTO study by the Dutch Colorectal Cancer Group

Johannes J.M. Kwakman, Lieke H. J. Simkens, Johan M. van Rooijen et al. · Annals of Oncology · 2017 · 83 citations

Medicine, Oncology, Pharmacology +12

Phase II study of bi-weekly administration of paclitaxel and cisplatin in patients with advanced oesophageal cancer

M. Polée, Ferry A.L.M. Eskens, M.E.L. van der Burg et al. · British Journal of Cancer · 2002 · 75 citations · Full text

Medicine, Oncology, Pharmacology +14

Perioperative or adjuvant mFOLFIRINOX for resectable pancreatic cancer (PREOPANC-3): study protocol for a multicenter randomized controlled trial

Jacob L. van Dam, Eva M. M. Verkolf, E.N. Dekker et al. · BMC Cancer · 2023 · 56 citations · Full text

Medicine, Oncology, Surgery +12